Product Information
CELECOXIB 100 MG CAPSULE is a generic product labeled by McKesson, priced at $0.0731 per EA under NDC 63739029710. Its NADAC has been published 78 times since Nov 6, 2024.
FDA first approved this application on Mar 16, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
McKessonNDC
63739029710
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
4/22/2026
Active Ingredients
CELECOXIBApproval Type
Generic (ANDA)
FDA Application
ANDA204590FDA Approved
3/16/2016
TE Code
AB
On Market Since
6/27/2024
Pharmacological Classes
Price Statistics
The NADAC for CELECOXIB 100 MG CAPSULE has been published 78 times since Nov 6, 2024, and over the history we have for it it has declined 12.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0731 per EA |
|---|---|
| All-time high | $0.0832 (Nov 13, 2024) |
| All-time low | $0.0581 (Nov 20, 2024) |
| 52-week high | $0.0741 |
| 52-week low | $0.0711 |
| Median price | $0.0733 |
| Average price | $0.0726 |
| Largest weekly change | -30.2% (Nov 20, 2024) |
| Weeks tracked | 78 |
| Tracking since | Nov 6, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
+2.7%
1Y
-0.1%
3Y
N/A
5Y
N/A
All
-12.2%
Last surveyed Apr 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
McKesson manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
celecoxib market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CELECOXIB 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 100 MG CAPSULE, manufactured by McKesson, is $0.0731 per EA (NDC 63739029710), effective Apr 29, 2026.
How has the price of CELECOXIB 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CELECOXIB 100 MG CAPSULE has declined 12.2%. It has been tracked across 78 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for CELECOXIB 100 MG CAPSULE?
Since Nov 6, 2024, the NADAC for CELECOXIB 100 MG CAPSULE has ranged from a low of $0.0581 (Nov 20, 2024) to a high of $0.0832 (Nov 13, 2024), with a median of $0.0733 per EA.
Are there cheaper alternatives to CELECOXIB 100 MG CAPSULE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CELECOXIB 100 MG CAPSULE, is $0.0614 per EA — about 16% below CELECOXIB 100 MG CAPSULE.
Who manufactures CELECOXIB 100 MG CAPSULE?
CELECOXIB 100 MG CAPSULE (NDC 63739029710) is labeled by McKesson, and CMS classifies it as a generic product.